Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 8, 2005, Pages 870-873

  Márquez, Manlio F ^a   Rivera, Jaime ^a   Hermosillo, Antonio G ^a   Iturralde, Pedro ^a   Colín, Luis ^a   Moragrega, José Luis ^a   Cárdenas, Manuel ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Arrhythmic storm; Brugada syndrome; Quinidine; Sudden cardiac death; Ventricular fibrillation

Indexed keywords

QUINIDINE SULFATE;

ADULT; ANAMNESIS; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DEFIBRILLATOR; DOSE RESPONSE; DRUG RESPONSE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PHYSICAL EXAMINATION; SYNCOPE; TREADMILL EXERCISE;

ADULT; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HUMANS; MALE; QUINIDINE; SYNCOPE, VASOVAGAL; SYNDROME; VENTRICULAR FIBRILLATION;

EID: 27744591929     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00183.x     Document Type: Article

References (18)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death. J Am Coll Cardiol 1992; 20:1391-1396.
2. Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome: 1992-2002. J Am Coll Cardiol 2003; 41:1665-1671.
3. Belhassen B, Viskin S, Antzelevitch C. The Brugada syndrome: Is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol 2002; 25:1634-1640.
4. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 1990; 120:661-671.
5. Belhassen B, Viskin S, Fish R, et al. Effects of electrophysiologic- guided therapy with Class IA antiarrhytmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10:1313-1315.
6. Alings M, Wilde A. "Brugada" syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666-673.
7. Villacastin J, Almendral J, Arenal A, et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996; 93:753-762.
8. Ayerza MR, de Zutter M, Numata O, et al. Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol 2002; 13:943-944.
9. Suzuki H, Torigoe K, Numata O, et al. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11:1277-1280.
10. Garg A, Finneran W, Feld G. Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 1998; 9:642-647.
11. Vidaurri A, Pastelín G, Méndez R, et al. El tratamiento de la fibrilación auricular con infusión intravenosa de quinidina. Arch Inst Cardiol Mex 1983; 53:5-11.
12. Imaizumi Y, Giles WR. Quinidine-induced inhibition of transient outward current in cardiac muscle. Am J Physiol 1987; 253:H704-H708.
13. Antzelevitch C, Yan GX, Shimizu W, et al. Electrical heterogeneity, the ECG, and cardiac arrhythmias. In: Zipes DP, Jalife J (eds.): Cardiac Electrophysiology. From Cell to Bedside, 3rd Ed. Philadelphia, W.B. Saunders Co., 2000, pp. 890-903.
14. Alings M, Dekker L, Sadee A, et al. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001; 24:1420-1422.
15. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in highrisk patients with Brugada syndrome. Circulation 2004; 110:1731-1737.
16. Hermida JS, Denjoy I, Clerc J, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004; 43:1853-1860.
17. Brugada P, Brugada J, Brugada R. The yet unresolved dilemma of syncope in Brugada syndrome. Europace 2001; 3:157-158.
18. Samniah N, Iskos D, Sakaguchi S, et al. Syncope in pharmacologically unmasked Brugada syndrome: Indication for an implantable defibrillator or an unresolved dilemma? Europace 2001; 3:159-163.